nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP3A4—bone cancer	0.822	1	CbGaD
Isoniazid—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00711	0.072	CbGpPWpGaD
Isoniazid—NAT2—Metapathway biotransformation—CYP4V2—bone cancer	0.00474	0.048	CbGpPWpGaD
Isoniazid—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00428	0.0433	CbGpPWpGaD
Isoniazid—Neurotoxicity—Cisplatin—bone cancer	0.00424	0.0537	CcSEcCtD
Isoniazid—CYP2A6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00296	0.0299	CbGpPWpGaD
Isoniazid—Diabetic—Methotrexate—bone cancer	0.0027	0.0343	CcSEcCtD
Isoniazid—Reaction gastrointestinal—Methotrexate—bone cancer	0.0027	0.0343	CcSEcCtD
Isoniazid—Optic neuritis—Cisplatin—bone cancer	0.00267	0.0339	CcSEcCtD
Isoniazid—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00234	0.0236	CbGpPWpGaD
Isoniazid—Neurotoxicity—Methotrexate—bone cancer	0.00233	0.0295	CcSEcCtD
Isoniazid—Neurotoxicity—Epirubicin—bone cancer	0.00218	0.0276	CcSEcCtD
Isoniazid—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00202	0.0204	CbGpPWpGaD
Isoniazid—Neurotoxicity—Doxorubicin—bone cancer	0.00202	0.0255	CcSEcCtD
Isoniazid—Liver injury—Cisplatin—bone cancer	0.00195	0.0248	CcSEcCtD
Isoniazid—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00193	0.0195	CbGpPWpGaD
Isoniazid—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0018	0.0182	CbGpPWpGaD
Isoniazid—CYP2A6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00171	0.0173	CbGpPWpGaD
Isoniazid—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00167	0.0168	CbGpPWpGaD
Isoniazid—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00166	0.0168	CbGpPWpGaD
Isoniazid—Hepatocellular injury—Cisplatin—bone cancer	0.00164	0.0208	CcSEcCtD
Isoniazid—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00164	0.0166	CbGpPWpGaD
Isoniazid—Body temperature increased—Carboplatin—bone cancer	0.00158	0.02	CcSEcCtD
Isoniazid—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00157	0.0159	CbGpPWpGaD
Isoniazid—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00157	0.0159	CbGpPWpGaD
Isoniazid—Eruption—Methotrexate—bone cancer	0.00147	0.0186	CcSEcCtD
Isoniazid—CYP2A6—Xenobiotics—CYP3A4—bone cancer	0.00143	0.0144	CbGpPWpGaD
Isoniazid—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0014	0.0142	CbGpPWpGaD
Isoniazid—NAT2—Phase II conjugation—GSTP1—bone cancer	0.00139	0.0141	CbGpPWpGaD
Isoniazid—Eruption—Epirubicin—bone cancer	0.00137	0.0174	CcSEcCtD
Isoniazid—Optic neuritis—Epirubicin—bone cancer	0.00137	0.0174	CcSEcCtD
Isoniazid—CYP2A6—Tamoxifen metabolism—CYP3A4—bone cancer	0.00137	0.0139	CbGpPWpGaD
Isoniazid—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00135	0.0136	CbGpPWpGaD
Isoniazid—Optic neuritis—Doxorubicin—bone cancer	0.00127	0.0161	CcSEcCtD
Isoniazid—Eruption—Doxorubicin—bone cancer	0.00127	0.0161	CcSEcCtD
Isoniazid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00126	0.0128	CbGpPWpGaD
Isoniazid—Neuritis—Epirubicin—bone cancer	0.00113	0.0143	CcSEcCtD
Isoniazid—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.00113	0.0114	CbGpPWpGaD
Isoniazid—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.00113	0.0114	CbGpPWpGaD
Isoniazid—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.00108	0.011	CbGpPWpGaD
Isoniazid—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00108	0.011	CbGpPWpGaD
Isoniazid—Neuritis—Doxorubicin—bone cancer	0.00105	0.0133	CcSEcCtD
Isoniazid—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00102	0.0103	CbGpPWpGaD
Isoniazid—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.00101	0.0102	CbGpPWpGaD
Isoniazid—Liver injury—Epirubicin—bone cancer	0.001	0.0127	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Methotrexate—bone cancer	0.000992	0.0126	CcSEcCtD
Isoniazid—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00098	0.00991	CbGpPWpGaD
Isoniazid—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000975	0.00986	CbGpPWpGaD
Isoniazid—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000956	0.00967	CbGpPWpGaD
Isoniazid—NAT2—Biological oxidations—CYP3A4—bone cancer	0.000951	0.00962	CbGpPWpGaD
Isoniazid—NAT2—Metapathway biotransformation—CYP3A4—bone cancer	0.000938	0.00949	CbGpPWpGaD
Isoniazid—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000937	0.00948	CbGpPWpGaD
Isoniazid—Hyperbilirubinaemia—Epirubicin—bone cancer	0.000929	0.0118	CcSEcCtD
Isoniazid—Liver injury—Doxorubicin—bone cancer	0.000929	0.0118	CcSEcCtD
Isoniazid—Vasculitis—Methotrexate—bone cancer	0.000925	0.0117	CcSEcCtD
Isoniazid—Neuropathy peripheral—Cisplatin—bone cancer	0.000902	0.0114	CcSEcCtD
Isoniazid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000888	0.00898	CbGpPWpGaD
Isoniazid—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.00087	0.0088	CbGpPWpGaD
Isoniazid—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000869	0.00879	CbGpPWpGaD
Isoniazid—Hyperbilirubinaemia—Doxorubicin—bone cancer	0.000859	0.0109	CcSEcCtD
Isoniazid—Aplastic anaemia—Methotrexate—bone cancer	0.000847	0.0107	CcSEcCtD
Isoniazid—Hepatocellular injury—Epirubicin—bone cancer	0.000845	0.0107	CcSEcCtD
Isoniazid—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000837	0.00846	CbGpPWpGaD
Isoniazid—NAT2—Biological oxidations—GSTP1—bone cancer	0.000813	0.00823	CbGpPWpGaD
Isoniazid—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00081	0.0082	CbGpPWpGaD
Isoniazid—Gynaecomastia—Methotrexate—bone cancer	0.000807	0.0102	CcSEcCtD
Isoniazid—NAT2—Metapathway biotransformation—GSTP1—bone cancer	0.000802	0.00811	CbGpPWpGaD
Isoniazid—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.0008	0.00809	CbGpPWpGaD
Isoniazid—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000793	0.00802	CbGpPWpGaD
Isoniazid—Aplastic anaemia—Epirubicin—bone cancer	0.000793	0.01	CcSEcCtD
Isoniazid—Hepatocellular injury—Doxorubicin—bone cancer	0.000781	0.0099	CcSEcCtD
Isoniazid—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000776	0.00785	CbGpPWpGaD
Isoniazid—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000769	0.00778	CbGpPWpGaD
Isoniazid—Lymphadenopathy—Methotrexate—bone cancer	0.000768	0.00973	CcSEcCtD
Isoniazid—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000763	0.00772	CbGpPWpGaD
Isoniazid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000759	0.00768	CbGpPWpGaD
Isoniazid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000756	0.00764	CbGpPWpGaD
Isoniazid—Diabetes mellitus—Methotrexate—bone cancer	0.000753	0.00954	CcSEcCtD
Isoniazid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000737	0.00746	CbGpPWpGaD
Isoniazid—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000737	0.00746	CbGpPWpGaD
Isoniazid—Aplastic anaemia—Doxorubicin—bone cancer	0.000734	0.00929	CcSEcCtD
Isoniazid—Lymphadenopathy—Epirubicin—bone cancer	0.000719	0.0091	CcSEcCtD
Isoniazid—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000713	0.00722	CbGpPWpGaD
Isoniazid—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000707	0.00715	CbGpPWpGaD
Isoniazid—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000706	0.00714	CbGpPWpGaD
Isoniazid—Diabetes mellitus—Epirubicin—bone cancer	0.000705	0.00893	CcSEcCtD
Isoniazid—Hepatic function abnormal—Epirubicin—bone cancer	0.000701	0.00889	CcSEcCtD
Isoniazid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000681	0.00689	CbGpPWpGaD
Isoniazid—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000678	0.00686	CbGpPWpGaD
Isoniazid—Ill-defined disorder—Cisplatin—bone cancer	0.000667	0.00845	CcSEcCtD
Isoniazid—Lymphadenopathy—Doxorubicin—bone cancer	0.000665	0.00842	CcSEcCtD
Isoniazid—Diabetes mellitus—Doxorubicin—bone cancer	0.000652	0.00826	CcSEcCtD
Isoniazid—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000652	0.00659	CbGpPWpGaD
Isoniazid—Hepatic function abnormal—Doxorubicin—bone cancer	0.000649	0.00822	CcSEcCtD
Isoniazid—Malaise—Cisplatin—bone cancer	0.000648	0.00821	CcSEcCtD
Isoniazid—Convulsion—Cisplatin—bone cancer	0.000623	0.00789	CcSEcCtD
Isoniazid—Discomfort—Cisplatin—bone cancer	0.000605	0.00766	CcSEcCtD
Isoniazid—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000604	0.00611	CbGpPWpGaD
Isoniazid—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000597	0.00604	CbGpPWpGaD
Isoniazid—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000592	0.00599	CbGpPWpGaD
Isoniazid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000586	0.00592	CbGpPWpGaD
Isoniazid—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000585	0.00591	CbGpPWpGaD
Isoniazid—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000579	0.00586	CbGpPWpGaD
Isoniazid—Thrombocytopenia—Cisplatin—bone cancer	0.000574	0.00728	CcSEcCtD
Isoniazid—NAT2—Metabolism—NDUFA12—bone cancer	0.00057	0.00577	CbGpPWpGaD
Isoniazid—Eosinophilia—Methotrexate—bone cancer	0.000561	0.0071	CcSEcCtD
Isoniazid—Anorexia—Cisplatin—bone cancer	0.000559	0.00709	CcSEcCtD
Isoniazid—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000545	0.00551	CbGpPWpGaD
Isoniazid—Paraesthesia—Cisplatin—bone cancer	0.000527	0.00667	CcSEcCtD
Isoniazid—Eosinophilia—Epirubicin—bone cancer	0.000525	0.00665	CcSEcCtD
Isoniazid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000519	0.00525	CbGpPWpGaD
Isoniazid—Decreased appetite—Cisplatin—bone cancer	0.00051	0.00646	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Cisplatin—bone cancer	0.000507	0.00642	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—bone cancer	0.000485	0.00615	CcSEcCtD
Isoniazid—Feeling abnormal—Cisplatin—bone cancer	0.000483	0.00613	CcSEcCtD
Isoniazid—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00048	0.00486	CbGpPWpGaD
Isoniazid—Hyperglycaemia—Epirubicin—bone cancer	0.000478	0.00606	CcSEcCtD
Isoniazid—NAT2—Metabolism—NT5C3A—bone cancer	0.000472	0.00478	CbGpPWpGaD
Isoniazid—Agranulocytosis—Methotrexate—bone cancer	0.000471	0.00597	CcSEcCtD
Isoniazid—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000468	0.00474	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000466	0.00472	CbGpPWpGaD
Isoniazid—Body temperature increased—Cisplatin—bone cancer	0.000464	0.00588	CcSEcCtD
Isoniazid—Neuropathy peripheral—Epirubicin—bone cancer	0.000463	0.00587	CcSEcCtD
Isoniazid—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000462	0.00467	CbGpPWpGaD
Isoniazid—Jaundice—Epirubicin—bone cancer	0.00046	0.00583	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—bone cancer	0.000453	0.00574	CcSEcCtD
Isoniazid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000443	0.00448	CbGpPWpGaD
Isoniazid—Hyperglycaemia—Doxorubicin—bone cancer	0.000442	0.0056	CcSEcCtD
Isoniazid—Agranulocytosis—Epirubicin—bone cancer	0.000441	0.00559	CcSEcCtD
Isoniazid—Hypersensitivity—Cisplatin—bone cancer	0.000432	0.00548	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—bone cancer	0.000428	0.00543	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—bone cancer	0.000426	0.0054	CcSEcCtD
Isoniazid—Hepatitis—Epirubicin—bone cancer	0.000424	0.00537	CcSEcCtD
Isoniazid—Asthenia—Cisplatin—bone cancer	0.000421	0.00533	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—bone cancer	0.000408	0.00517	CcSEcCtD
Isoniazid—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000405	0.00409	CbGpPWpGaD
Isoniazid—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000399	0.00404	CbGpPWpGaD
Isoniazid—Hepatitis—Doxorubicin—bone cancer	0.000392	0.00497	CcSEcCtD
Isoniazid—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000382	0.00387	CbGpPWpGaD
Isoniazid—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00038	0.00384	CbGpPWpGaD
Isoniazid—Vomiting—Cisplatin—bone cancer	0.000373	0.00473	CcSEcCtD
Isoniazid—Rash—Cisplatin—bone cancer	0.00037	0.00469	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—bone cancer	0.000366	0.00464	CcSEcCtD
Isoniazid—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000361	0.00365	CbGpPWpGaD
Isoniazid—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000356	0.00361	CbGpPWpGaD
Isoniazid—Malaise—Methotrexate—bone cancer	0.000356	0.00451	CcSEcCtD
Isoniazid—Nausea—Cisplatin—bone cancer	0.000349	0.00442	CcSEcCtD
Isoniazid—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000348	0.00352	CbGpPWpGaD
Isoniazid—Ill-defined disorder—Epirubicin—bone cancer	0.000343	0.00434	CcSEcCtD
Isoniazid—Convulsion—Methotrexate—bone cancer	0.000342	0.00433	CcSEcCtD
Isoniazid—Malaise—Epirubicin—bone cancer	0.000333	0.00422	CcSEcCtD
Isoniazid—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000332	0.00336	CbGpPWpGaD
Isoniazid—Discomfort—Methotrexate—bone cancer	0.000332	0.0042	CcSEcCtD
Isoniazid—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000329	0.00333	CbGpPWpGaD
Isoniazid—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000328	0.00332	CbGpPWpGaD
Isoniazid—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000328	0.00332	CbGpPWpGaD
Isoniazid—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000325	0.00329	CbGpPWpGaD
Isoniazid—Convulsion—Epirubicin—bone cancer	0.00032	0.00405	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—bone cancer	0.000317	0.00402	CcSEcCtD
Isoniazid—Thrombocytopenia—Methotrexate—bone cancer	0.000315	0.00399	CcSEcCtD
Isoniazid—Discomfort—Epirubicin—bone cancer	0.000311	0.00393	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—bone cancer	0.000308	0.0039	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—bone cancer	0.000307	0.00389	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—bone cancer	0.000296	0.00375	CcSEcCtD
Isoniazid—Thrombocytopenia—Epirubicin—bone cancer	0.000295	0.00374	CcSEcCtD
Isoniazid—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000293	0.00296	CbGpPWpGaD
Isoniazid—Paraesthesia—Methotrexate—bone cancer	0.000289	0.00366	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—bone cancer	0.000287	0.00364	CcSEcCtD
Isoniazid—Anorexia—Epirubicin—bone cancer	0.000287	0.00364	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—bone cancer	0.000283	0.00359	CcSEcCtD
Isoniazid—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000281	0.00285	CbGpPWpGaD
Isoniazid—Decreased appetite—Methotrexate—bone cancer	0.00028	0.00355	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Methotrexate—bone cancer	0.000278	0.00352	CcSEcCtD
Isoniazid—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000278	0.00281	CbGpPWpGaD
Isoniazid—Fatigue—Methotrexate—bone cancer	0.000278	0.00352	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—bone cancer	0.000273	0.00346	CcSEcCtD
Isoniazid—Paraesthesia—Epirubicin—bone cancer	0.000271	0.00343	CcSEcCtD
Isoniazid—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000269	0.00272	CbGpPWpGaD
Isoniazid—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000267	0.0027	CbGpPWpGaD
Isoniazid—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000266	0.00269	CbGpPWpGaD
Isoniazid—Anorexia—Doxorubicin—bone cancer	0.000266	0.00337	CcSEcCtD
Isoniazid—Feeling abnormal—Methotrexate—bone cancer	0.000265	0.00336	CcSEcCtD
Isoniazid—Dyspepsia—Epirubicin—bone cancer	0.000265	0.00336	CcSEcCtD
Isoniazid—Decreased appetite—Epirubicin—bone cancer	0.000262	0.00332	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Epirubicin—bone cancer	0.00026	0.0033	CcSEcCtD
Isoniazid—Fatigue—Epirubicin—bone cancer	0.00026	0.00329	CcSEcCtD
Isoniazid—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000255	0.00258	CbGpPWpGaD
Isoniazid—Body temperature increased—Methotrexate—bone cancer	0.000255	0.00322	CcSEcCtD
Isoniazid—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000252	0.00255	CbGpPWpGaD
Isoniazid—Paraesthesia—Doxorubicin—bone cancer	0.00025	0.00317	CcSEcCtD
Isoniazid—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000249	0.00252	CbGpPWpGaD
Isoniazid—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000249	0.00252	CbGpPWpGaD
Isoniazid—Feeling abnormal—Epirubicin—bone cancer	0.000248	0.00315	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—bone cancer	0.000245	0.00311	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—bone cancer	0.000242	0.00307	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000241	0.00305	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—bone cancer	0.00024	0.00305	CcSEcCtD
Isoniazid—Body temperature increased—Epirubicin—bone cancer	0.000238	0.00302	CcSEcCtD
Isoniazid—Hypersensitivity—Methotrexate—bone cancer	0.000237	0.00301	CcSEcCtD
Isoniazid—Asthenia—Methotrexate—bone cancer	0.000231	0.00293	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—bone cancer	0.00023	0.00291	CcSEcCtD
Isoniazid—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000228	0.00231	CbGpPWpGaD
Isoniazid—Hypersensitivity—Epirubicin—bone cancer	0.000222	0.00281	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—bone cancer	0.00022	0.00279	CcSEcCtD
Isoniazid—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000218	0.00221	CbGpPWpGaD
Isoniazid—Asthenia—Epirubicin—bone cancer	0.000216	0.00274	CcSEcCtD
Isoniazid—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000207	0.0021	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—ENO2—bone cancer	0.000207	0.00209	CbGpPWpGaD
Isoniazid—Hypersensitivity—Doxorubicin—bone cancer	0.000205	0.0026	CcSEcCtD
Isoniazid—Vomiting—Methotrexate—bone cancer	0.000205	0.00259	CcSEcCtD
Isoniazid—Rash—Methotrexate—bone cancer	0.000203	0.00257	CcSEcCtD
Isoniazid—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000202	0.00204	CbGpPWpGaD
Isoniazid—Asthenia—Doxorubicin—bone cancer	0.0002	0.00253	CcSEcCtD
Isoniazid—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000199	0.00201	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—DHFR—bone cancer	0.000192	0.00194	CbGpPWpGaD
Isoniazid—Vomiting—Epirubicin—bone cancer	0.000192	0.00243	CcSEcCtD
Isoniazid—Nausea—Methotrexate—bone cancer	0.000191	0.00242	CcSEcCtD
Isoniazid—Rash—Epirubicin—bone cancer	0.00019	0.00241	CcSEcCtD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000188	0.0019	CbGpPWpGaD
Isoniazid—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000185	0.00187	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—GNA11—bone cancer	0.000179	0.00181	CbGpPWpGaD
Isoniazid—Nausea—Epirubicin—bone cancer	0.000179	0.00227	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—bone cancer	0.000177	0.00225	CcSEcCtD
Isoniazid—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000177	0.00179	CbGpPWpGaD
Isoniazid—Rash—Doxorubicin—bone cancer	0.000176	0.00223	CcSEcCtD
Isoniazid—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000174	0.00176	CbGpPWpGaD
Isoniazid—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000172	0.00174	CbGpPWpGaD
Isoniazid—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000172	0.00174	CbGpPWpGaD
Isoniazid—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.00017	0.00172	CbGpPWpGaD
Isoniazid—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000169	0.00171	CbGpPWpGaD
Isoniazid—Nausea—Doxorubicin—bone cancer	0.000166	0.0021	CcSEcCtD
Isoniazid—NAT2—Metabolism—CYP3A4—bone cancer	0.000163	0.00165	CbGpPWpGaD
Isoniazid—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.00016	0.00162	CbGpPWpGaD
Isoniazid—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000156	0.00157	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000154	0.00156	CbGpPWpGaD
Isoniazid—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000153	0.00155	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000153	0.00155	CbGpPWpGaD
Isoniazid—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000149	0.00151	CbGpPWpGaD
Isoniazid—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000147	0.00149	CbGpPWpGaD
Isoniazid—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000144	0.00146	CbGpPWpGaD
Isoniazid—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.000143	0.00145	CbGpPWpGaD
Isoniazid—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000142	0.00143	CbGpPWpGaD
Isoniazid—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000141	0.00143	CbGpPWpGaD
Isoniazid—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.00014	0.00141	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—GSTP1—bone cancer	0.000139	0.00141	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000139	0.00141	CbGpPWpGaD
Isoniazid—CYP2C19—Biological oxidations—GSTP1—bone cancer	0.000133	0.00135	CbGpPWpGaD
Isoniazid—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	0.000131	0.00133	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—NT5C3A—bone cancer	0.000127	0.00128	CbGpPWpGaD
Isoniazid—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000123	0.00125	CbGpPWpGaD
Isoniazid—CYP2D6—Biological oxidations—GSTP1—bone cancer	0.000122	0.00124	CbGpPWpGaD
Isoniazid—CYP2C9—Biological oxidations—GSTP1—bone cancer	0.000121	0.00123	CbGpPWpGaD
Isoniazid—CYP1A2—Biological oxidations—CYP3A4—bone cancer	0.000121	0.00123	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NDUFA12—bone cancer	0.000121	0.00122	CbGpPWpGaD
Isoniazid—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	0.000121	0.00122	CbGpPWpGaD
Isoniazid—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	0.00012	0.00121	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	0.00012	0.00121	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000109	0.00111	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000109	0.00111	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NDUFA12—bone cancer	0.000104	0.00106	CbGpPWpGaD
Isoniazid—CYP1A2—Biological oxidations—GSTP1—bone cancer	0.000104	0.00105	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	0.000102	0.00103	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NT5C3A—bone cancer	0.0001	0.00101	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NDUFA12—bone cancer	9.32e-05	0.000943	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NT5C3A—bone cancer	8.66e-05	0.000875	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NDUFA12—bone cancer	8.58e-05	0.000867	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NDUFA12—bone cancer	8.5e-05	0.00086	CbGpPWpGaD
Isoniazid—CYP3A4—Biological oxidations—GSTP1—bone cancer	8e-05	0.000809	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	7.89e-05	0.000798	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NT5C3A—bone cancer	7.73e-05	0.000781	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NDUFA12—bone cancer	7.26e-05	0.000735	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—PTGS2—bone cancer	7.21e-05	0.000729	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NT5C3A—bone cancer	7.11e-05	0.000719	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NT5C3A—bone cancer	7.04e-05	0.000712	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NT5C3A—bone cancer	6.02e-05	0.000609	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NDUFA12—bone cancer	5.61e-05	0.000567	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ENO2—bone cancer	5.55e-05	0.000561	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—DHFR—bone cancer	5.15e-05	0.000521	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GNA11—bone cancer	4.81e-05	0.000487	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NT5C3A—bone cancer	4.65e-05	0.00047	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ENO2—bone cancer	4.39e-05	0.000444	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CYP3A4—bone cancer	4.36e-05	0.000441	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—DHFR—bone cancer	4.07e-05	0.000412	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GNA11—bone cancer	3.8e-05	0.000385	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ENO2—bone cancer	3.79e-05	0.000383	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GSTP1—bone cancer	3.73e-05	0.000377	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—DHFR—bone cancer	3.52e-05	0.000356	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP3A4—bone cancer	3.45e-05	0.000349	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ENO2—bone cancer	3.38e-05	0.000342	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GNA11—bone cancer	3.29e-05	0.000332	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—DHFR—bone cancer	3.14e-05	0.000318	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ENO2—bone cancer	3.11e-05	0.000315	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ENO2—bone cancer	3.09e-05	0.000312	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP3A4—bone cancer	2.98e-05	0.000301	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.96e-05	0.0003	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTP1—bone cancer	2.95e-05	0.000298	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GNA11—bone cancer	2.93e-05	0.000297	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—DHFR—bone cancer	2.89e-05	0.000292	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—DHFR—bone cancer	2.86e-05	0.00029	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GNA11—bone cancer	2.7e-05	0.000273	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GNA11—bone cancer	2.68e-05	0.000271	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP3A4—bone cancer	2.66e-05	0.000269	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.65e-05	0.000268	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ENO2—bone cancer	2.64e-05	0.000267	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTP1—bone cancer	2.55e-05	0.000258	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP3A4—bone cancer	2.45e-05	0.000247	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—DHFR—bone cancer	2.45e-05	0.000247	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP3A4—bone cancer	2.43e-05	0.000245	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.41e-05	0.000244	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GNA11—bone cancer	2.29e-05	0.000231	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTP1—bone cancer	2.28e-05	0.00023	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTP1—bone cancer	2.09e-05	0.000212	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTP1—bone cancer	2.07e-05	0.00021	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP3A4—bone cancer	2.07e-05	0.00021	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.06e-05	0.000209	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ENO2—bone cancer	2.03e-05	0.000206	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTGS2—bone cancer	1.93e-05	0.000196	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—DHFR—bone cancer	1.89e-05	0.000191	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTP1—bone cancer	1.77e-05	0.000179	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GNA11—bone cancer	1.76e-05	0.000178	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTGS2—bone cancer	1.53e-05	0.000155	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTP1—bone cancer	1.37e-05	0.000138	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTGS2—bone cancer	1.32e-05	0.000134	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTGS2—bone cancer	1.18e-05	0.000119	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTGS2—bone cancer	1.08e-05	0.00011	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTGS2—bone cancer	1.07e-05	0.000109	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTGS2—bone cancer	9.18e-06	9.29e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTGS2—bone cancer	7.09e-06	7.17e-05	CbGpPWpGaD
